Treatment for Lung Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
London Health Sciences Centre, London, CanadaLung Cancer+2 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether people who have surgery to remove part of their lung can be safely discharged the same day.

Eligible Conditions
  • Lung Cancer
  • Surgery
  • Minor

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 2 years

2 years
Rate of successful same day discharge

Trial Safety

Trial Design

0 Treatment Group

60 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
620 Previous Clinical Trials
403,194 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

How many individuals have committed to participating in this research endeavor?

"Affirmative. The clinicaltrials.gov website lists this medical trial as actively seeking participants, with the initial posting dating back to December 23rd 2021 and the latest update occurring on April 19th 2022. Sixty patients must be enrolled at one specific site before the study can move forward." - Anonymous Online Contributor

Unverified Answer

Are there any still-available slots for participants in this research?

"This clinical trial is still in search of enrollees, according to the content on clinicaltrials.gov. It was initially uploaded on December 23rd 2021 and most recently updated on April 19th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.